Outpatient parenteral antimicrobial therapy (OPAT) is the practice of using intravenous antimicrobial drugs for treatment in an ambulatory setting. OPAT is usually administered via a central catheter, either a long-term surgically implanted device or peripherally inserted central catheter. Although OPAT has a long track record of effectiveness, complications are common [1] [2] [3] . The direct (line placement, supplies, nursing visits) and indirect medical costs for caregivers are substantial.
In the era of antimicrobial stewardship, awareness that OPAT is often used inappropriately and should be a stewardship target is growing. Many factors contribute to inappropriate OPAT use, including unnecessary treatment as a result of contaminated blood cultures, dosing errors, and inadequate laboratory monitoring for toxicity. Perhaps the most important issue is the underuse of equally effective oral therapy. Results from recent studies of pediatric OPAT use suggest that up to 40% of OPAT courses could be managed with oral therapy instead; this situation might be improved with more input from infectious diseases (ID) specialists [2, 4] . At our hospital, fewer than 50% of OPAT courses involved ID consultation [4] , despite recommendations from the Infectious Diseases Society of America that all OPAT candidates undergo review by a clinician with ID expertise [5] . In 2014, we started a stewardship program to improve the quality, safety, and value of OPAT use. Our objective was to evaluate the effect of such stewardship on OPAT utilization.
METHODS

Study Design, Setting, and Population
This was a quasi-experimental pre-post study of hospitalized patients at Primary Children's Hospital (PCH), a 289-bed freestanding children's hospital in Salt Lake City, Utah. We divided the study into 2 periods, preintervention (May 2013 to April 2014) and intervention (May 2014 to May 2015). The eligible study population included all patients discharged from PCH. This study was reviewed and granted approval by the institutional review board of the University of Utah and PCH.
Antimicrobial Stewardship Intervention
During the preintervention period, PCH provided support for an inpatient stewardship program (initiated in 2010) that consisted of 1 physician (0.5 effort) and 1 pharmacist (1.0 effort). The program used a prospective-audit structure and conducted week-day review of all hospitalized children who were receiving antimicrobial drugs (24-72 hours after initiation) and had previous authorization for selected antimicrobial drugs but in this period did not routinely review OPAT prescriptions at the time of discharge. The OPAT stewardship intervention expanded the scope of stewardship activities to encompass review of all discharge cases considered or planned for OPAT that did not include ID consultation. We incorporated 4 new strategies to detect and review the cases of patients being discharged with an OPAT prescription (OPAT discharges): (1) stewardship team review/recommendations included input regarding discharge treatment; (2) the peripherally inserted central catheter team paged the stewardship team before line placement if the designated purpose was OPAT; (3) care coordinators paged the stewardship team when arranging home care for OPAT; and (4) discharge planning software was modified to generate an electronic alert via text message to the stewardship team when discharge medications included OPAT.
Study Outcomes
We included 2 primary outcomes, (1) OPAT use, measured as the number of patients per month discharged with OPAT per review, measured as the monthly percentage of OPAT discharge cases reviewed by the stewardship team or that had undergone ID consultation. Additional secondary outcomes included stewardship recommendations, OPAT indications, and OPAT complications (unplanned emergency department visit or hospitalization for line clot, dislodgement, or infection). A balance measure was the percentage of patients who were discharged on oral antimicrobials and readmitted within 30 days. We selected this metric because we hypothesized that an unintended consequence of our intervention might be increased treatment failure as a result of shifting from OPAT to oral therapy.
Statistical Methods
To compare the average monthly rates of OPAT use and OPAT review, we used interrupted time series (ITS) models with segmented linear regression. To compare proportions and continuous variables between periods, we used χ 2 and Mann-Whitney tests. Statistical analyses were performed in R 3.0.2.
RESULTS
During the study period overall, there were 776 patients discharged with OPAT (421 during preintervention and 355 during the intervention period). For these patients, we observed no differences in median length of hospital stay (4 days in each period) and median duration of OPAT after discharge (10 days in each period). The most commonly prescribed antimicrobials in each period were cefepime, ceftriaxone, vancomycin, and cefazolin.
Antimicrobial Use at Hospital Discharge
The percentages of patients discharged with antimicrobials were nearly identical between the preintervention and the intervention periods (5456 of 17 914 [30.5%] vs 5961 of 19 943 [29.9%]; P = .23). OPAT was prescribed for 7.7% of the patients discharged with antimicrobial agents during the preintervention period and declined to 6.1% (P < .01) of the patients discharged with antimicrobials during the intervention period.
OPAT Use
The average monthly OPAT utilization was 23.4 per 1000 discharges during the preintervention period and 17.8 per 1000 discharges during the intervention period ( Figure 1A ). Projected trends from the preintervention period indicated that OPAT use was increasing. The results of the ITS analysis indicate that the intervention period was associated with a 6.7% (95% confidence interval, 2.2%-11.2%) monthly reduction in the expected rate of OPAT utilization (P = .004).
OPAT Review
During the preintervention period, 47% of children discharged on OPAT underwent ID consultation ( Figure 1B) . After beginning OPAT stewardship, the ITS model indicates that this rate increased to 87% and was sustained (P < .001). The stewardship team reviewed 183 patients with planned OPAT without ID consultation; a recommendation was offered for 70 (38%) patients. The most common recommendation was to change the antimicrobial(s) used in the OPAT regimen (41% of recommendations), followed by intravenous-to-oral medication conversion and stopping antibiotic therapy altogether (14% each).
Secondary Outcomes
The leading clinical indication for OPAT was fever/neutropenia, which accounted for more than 100 OPAT courses in each period and 25% of overall OPAT use. Other common indications included bloodstream infection, osteoarticular infection, surgical site infection, and respiratory infection. Among patients discharged with antimicrobials (antibiotic discharges), we observed declines in the rate of OPAT use for osteoarticular (9.3 to 4.4 per 1000 antibiotic discharges; P < .01), surgical site (5.7 to 3.0 per 1000 antibiotic discharges; P = .03), and respiratory (5.5 to 1.2 per 1000 antibiotic discharges; P < .01) infections during the intervention period.
During both periods, 11% of the patients discharged on OPAT experienced a catheter complication (46 in the preintervention period and 40 during the intervention), which corresponds to a rate of 8.4 per 1000 antibiotic discharges in the preintervention period compared with 6.8 per 1000 antibiotic discharges during the intervention period (P = .29). We observed no change in the percentage of patients discharged with oral antimicrobials who required readmission for any cause (12.7% and 12.5% in the preintervention and intervention periods, respectively).
DISCUSSION
Introduction of an OPAT stewardship program enabled identification and ID expert review of nearly all patients who were being prepared for discharge with OPAT and was associated with a 6.7% monthly reduction (24% overall) in OPAT use. More specifically, a reduction in OPAT use was observed for conditions in which evidence supports the use of oral therapy in place of intravenous therapy (e.g., osteoarticular and respiratory infections) [6, 7] .
In studies of OPAT stewardship in adults, ID expert review before discharge frequently resulted in the modification of treatment plans, including discontinuation of therapy and conversion to oral therapy [8] [9] [10] . Results of previous reviews of pediatric OPAT suggest that similar opportunities to optimize OPAT use through stewardship exist [2, 4] . The impact of OPAT stewardship in our children's hospital was substantial. If preintervention OPAT utilization trends were projected into the intervention period, the stewardship intervention resulted in 114 OPAT courses averted in 1 year, including the avoidance of central line placement in the majority of them. Reduction in OPAT use has the potential enhanced clinical value of lowering medical costs and reducing unnecessary complications. We previously reported that the per-patient home care charges for OPAT in our system were approximately $1000/week [4] . When applied to our estimate for averted OPAT courses, the total exceeds $160 000 in annual home care charges. However, the economic implications of averting unnecessary OPAT use are considerably greater when we include other direct and indirect costs, such as savings on central line placement, avoidable central line complications, and indirect costs for children and their caregivers in terms of time spent administering the OPAT.
We observed declines in OPAT use for osteoarticular and respiratory infections (including empyema). Recent evidence indicates that for patients with one of these diagnoses, outcomes are equivalent between those treated with oral therapy and those undergoing OPAT, but oral therapy has a lower cost and prevents central catheter complications [6, 7] . At many children's hospitals (including ours), patients with osteoarticular infection and empyema routinely undergo ID consultation, which suggests that ID physicians themselves are important targets for OPAT stewardship. The overall decline in OPAT use seems to have been driven by both direct stewardship review and secondary effects on ID physicians managing patients who did not have stewardship review.
Our study had limitations. The study had a pre-post design without a concurrent control group. Although we used ITS analysis, it is likely that ongoing changes in ID clinical practice that contributed to changes in OPAT use would have occurred simultaneously. Changes in the rate of hospitalization for selected conditions that were potentially eligible for OPAT could have biased our results. However, we found no change in the overall rate of hospitalization between the preintervention and intervention periods for fever/neutropenia, osteoarticular, or respiratory infections, which are 3 common conditions treated with OPAT.
In summary, our OPAT stewardship intervention enabled the identification and review of patients discharged with OPAT and was associated with a reduction in OPAT use. Our experience suggests that pediatric stewardship programs should incorporate OPAT review into daily practice.
Notes
